ARCHIVES

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

FDA to refer false statements by regulated companies to SEC.

February 27, 2004

Chromosomal Abnormalities Predict Long Median Survival

January 27, 2012

Cancer Leadership Council letter calls for permanent leadership of NCI and FDA.

November 23, 2005

PET Better At Evaluating Response In Sarcoma

February 29, 2008

Low-Income Women Lack Mammography Access: Survey

May 14, 1993

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

April 27, 2007